Genfit (NASDAQ:GNFT – Get Free Report) and Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, valuation and risk. Volatility and Risk Genfit has a beta of 1.08, […]
VANCOUVER, British Columbia, March 12, 2024 (GLOBE NEWSWIRE) Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the Stifel 2024
TimesSquare Capital Management LLC Has $20 17 Million Stock Holdings in Xenon Pharmaceuticals Inc (NASDAQ:XENE) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Polar Capital Holdings Plc reduced its stake in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 0.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,003,747 shares of the biopharmaceutical company’s stock after selling 18,324 shares during […]
Polar Capital Holdings Plc reduced its holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 0.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,003,747 shares of the biopharmaceutical company’s stock after selling 18,324 shares during the period. Polar […]